X-Chem, Vertex to Jointly Develop Small Molecules for CF, Other Severe Genetic Diseases
cystic fibrosis, News
X-Chem Pharmaceuticals and Vertex Pharmaceuticals will jointly develop small molecules targeting cystic fibrosis (CF) and other severe genetic diseases. Under the collaboration announced May 16, X-Chem will apply its proprietary DEX libraries — which ... Read more